Research shows creatine may slow tumor growth and enhance immune cell activity — Evidence Review

Creatine, a supplement commonly used to boost athletic performance, may also enhance the anti-cancer immune response by powering dendritic cells, according to new research from UCLA. While some related studies support creatine’s potential to stimulate anti-tumor immunity, others report conflicting or context-dependent effects.

• Several studies show that creatine supplementation can slow tumor growth and enhance immune cell function, particularly in T cells, aligning with the new findings, though these effects may vary by cancer type and model 3 5.
• Contradictory research suggests creatine can also promote metastasis or tumor progression in some settings, indicating that its effects are complex and may depend on the tumor microenvironment or cell type involved 2 4 6.
• The new study’s focus on dendritic cells broadens previous work that primarily examined T cells, highlighting the importance of metabolic support for the entire immune response and suggesting possible benefits for cancer vaccine development 5 8 9 10 11 12.

Study Overview and Key Findings

The new UCLA study investigates whether creatine, best known for its role in muscle energy metabolism, might also bolster the immune system’s capacity to recognize and attack cancer. This research is timely as immunotherapies, which rely largely on T cell activation, currently benefit only a subset of cancer patients. By examining creatine’s effect on dendritic cells—specialized immune cells that orchestrate the body’s anti-tumor response—the study explores a novel approach to enhancing cancer immunotherapy and vaccine effectiveness.

Property	Value
Organization	UCLA
Journal Name	iScience
Authors	Lili Yang, James Elsten-Brown, Elliot Kang
Population	Mice, human cells, human immune cells
Outcome	Dendritic cell activity, tumor growth, immune response
Results	Creatine slowed tumor growth and boosted dendritic cell activity.

Literature Review: Related Studies

To contextualize the new findings, we searched the Consensus database—covering over 200 million research papers—using the following queries:

1. creatine cancer treatment effects
2. tumor growth inhibition creatine
3. dendritic cell activity cancer therapy

Topic	Key Findings
Does creatine supplementation inhibit or promote tumor growth?	- Creatine supplementation can slow tumor growth and reduce inflammation in some models, but does not improve survival rates 3. - In other studies, creatine, or the creatine imported by tumor cells, promotes tumor progression and metastasis, particularly in certain cancers or metabolic contexts 2 4 6.
How does creatine affect immune cell function in cancer therapy?	- Creatine can enhance the anti-tumor activity of T cells and potentially improve outcomes of T cell-based immunotherapies 5. - The new study extends this to dendritic cells, showing that creatine supports their activation and ability to prime T cells, potentially improving immunotherapy and vaccine efficacy 5 8 9 10 11 12.
What is the role of dendritic cells in cancer immunotherapy and how can their activity be enhanced?	- Dendritic cell-based immunotherapies are generally safe and can induce anti-tumor immunity, but clinical response rates remain modest, highlighting the need for strategies to boost dendritic cell function 9 11. - Understanding dendritic cell metabolism and the tumor microenvironment is critical for optimizing their anti-cancer functions 8 10 12.
Are there risks or unintended effects of manipulating creatine metabolism in cancer?	- Inhibition of creatine transport in tumor cells can suppress cancer progression, suggesting that creatine may have divergent effects on immune cells versus tumor cells 1 4 6. - Some studies indicate that exogenous creatine can promote cancer metastasis and tumor growth under specific conditions, underscoring the need for caution 2 4 6.

Does creatine supplementation inhibit or promote tumor growth?

The evidence regarding creatine’s effect on tumor growth is mixed. Some animal studies report that creatine supplementation can slow tumor progression and reduce markers of inflammation and oxidative stress, but do not show improved survival rates 3. In contrast, other research finds that creatine, either through dietary supplementation or metabolic transfer from other cells, can actually promote tumor progression, especially in cancers such as colorectal, breast, and glioblastoma, sometimes by supporting tumor cell survival in hypoxic environments 2 4 6.

• Creatine’s impact on tumor growth appears highly dependent on cancer type, metabolic context, and how creatine is utilized by different cells 2 3 4 6.
• Inhibition of creatine uptake in tumor cells can blunt tumor growth, suggesting dual roles for creatine depending on the target cell population 1.
• While some data point to anti-tumor effects, others indicate risk of enhanced metastasis from creatine supplementation, especially where tumor cells can exploit creatine metabolism 2 4.
• The net effect of creatine on cancer likely reflects a balance between immune activation and tumor cell metabolic adaptations 2 3 4 6.

How does creatine affect immune cell function in cancer therapy?

Multiple studies highlight the importance of creatine in powering immune cells, particularly T cells, during anti-tumor responses. Creatine supplementation has been shown to enhance T cell metabolic capacity, improve anti-tumor immunity, and even act synergistically with existing immunotherapies in preclinical models 5. The new UCLA study broadens this focus by showing that dendritic cells, which orchestrate T cell activation, also depend on creatine for optimal function 5 8 9 10 11 12.

• Creatine serves as a crucial energy source for T cells, and its uptake is necessary for robust anti-tumor activity 5.
• Supplementation can synergize with checkpoint inhibitor therapies in animal models, suggesting a potential for combinatorial strategies 5.
• The new findings indicate dendritic cells also require creatine, suggesting broader immune system benefits beyond T cells 5 8 9 10 11 12.
• Enhancing dendritic cell metabolism could improve both direct anti-tumor immunity and the effectiveness of cancer vaccines 8 9 11 12.

What is the role of dendritic cells in cancer immunotherapy and how can their activity be enhanced?

Dendritic cells are essential for initiating and orchestrating anti-tumor immune responses, making them key targets for immunotherapy. However, clinical response rates to dendritic cell-based vaccines and therapies have been limited, partly due to immunosuppressive tumor environments and insufficient dendritic cell activation 9 11. Recent research, including the new UCLA study, suggests that metabolic support—such as creatine supplementation—could enhance dendritic cell function, leading to more effective immune priming and improved therapy outcomes 8 9 10 11 12.

• Dendritic cell-based immunotherapies are generally safe but have low objective response rates, indicating a need for improved strategies 9 11.
• The tumor microenvironment can suppress dendritic cell function, emphasizing the importance of metabolic interventions 8 10 12.
• Creatine’s ability to boost dendritic cell activation and T cell priming may overcome some barriers to successful immunotherapy 5 8 9 10 11 12.
• Understanding dendritic cell biology and metabolism is crucial for developing new combination therapies and vaccines 8 9 10 11 12.

Are there risks or unintended effects of manipulating creatine metabolism in cancer?

While creatine may benefit immune cells, its effects on tumor cells are less predictable. Several studies have shown that blocking creatine transport into tumor cells can inhibit tumor growth, while others caution that creatine supplementation could enhance metastasis or tumor survival in specific contexts 1 2 4 6. This duality underscores the need for careful consideration of patient selection, cancer type, and metabolic status when considering creatine as an adjunct to cancer therapy.

• Creatine transport inhibitors suppress tumor progression, suggesting that tumor cells may use creatine for growth and survival 1 4.
• Creatine supplementation has been associated with increased metastasis in animal models of colorectal and breast cancer 2 6.
• The effects of creatine may differ between immune cells and cancer cells, highlighting the complexity of targeting metabolic pathways in cancer 1 2 4 6.
• Clinical translation will require careful assessment of risks and benefits in different patient populations 2 4 6.

Future Research Questions

Despite promising preclinical results, the effects of creatine supplementation in cancer patients remain untested, and its impact may vary across cancers and individual metabolic contexts. Further research is needed to clarify its safety, efficacy, and mechanisms of action in human cancer therapy.

Research Question	Relevance
Does creatine supplementation improve clinical outcomes for cancer patients receiving immunotherapy?	Direct clinical evidence is lacking; determining benefit and safety in patients is essential for translation into practice 3 5 9.
What are the risks of creatine promoting tumor growth or metastasis in certain cancer types?	Some preclinical studies report increased metastasis or tumor progression with creatine in specific contexts, so safety profiles must be established for different cancers 2 4 6.
How does creatine affect the function and phenotype of different dendritic cell subsets in human tumors?	The role of dendritic cell subsets in cancer is complex; understanding how creatine impacts these populations could guide more targeted therapies 8 10 11 12.
Can creatine supplementation enhance the effectiveness of dendritic cell-based cancer vaccines in clinical settings?	The new study suggests potential benefits, but this has yet to be tested in human vaccine protocols 9 11 12.
What are the mechanisms by which tumor cells and immune cells differentially utilize creatine?	Clarifying these mechanisms could help maximize immune benefits while minimizing risks of tumor promotion 1 2 4 5 6.